WASHINGTON, June 24, 2013 /PRNewswire-USNewswire/ -- The following is being released by the American Association for Justice:
Today the U.S. Supreme Court issued another handout to the generic drug industry, shielding it from lawsuits for the design of their drugs at the cost of consumer safety. In a 5-4 decision in Mutual Pharmaceutical Co. v. Bartlett the Court, once again, let a generic drug manufacturer off the hook for the safety of the drugs they produce.
Despite lower court rulings in favor of Karen Bartlett that the drug she took is an unreasonably unsafe drug, SCOTUS sided with Mutual and decided that they cannot be held responsible for the design of their drugs.
WHAT: Press call on SCOTUS decision in Mutual Pharmaceutical Co. v. Bartlett
WHEN: TODAY, Monday, June 24, 2013, at 2:30 p.m. EDT
Lou Bograd with the Center for Constitutional Litigation
Allison Zieve with Public Citizen
Sue Steinman with the American Association for Justice
David Fredrick argued this case for Bartlett in front of SCOTUS
CALL-IN #: 1-800-434-1335; Conference Code: 971187#
Mutual Pharmaceutical Co. v. Bartlett (argued March 19, 2013)
AAJ filed comments in support of Public Citizen's citizen petition asking the FDA to address the Mensing decision. Public Citizen also issued a new report today highlighting how many potential hazards are not discovered until years after drugs have been on the market and the risk this poses to patients.
For more information on generic drugs, please visit www.TakeJusticeBack.com/GenericDrugs.
As the world's largest trial bar, the American Association for Justice (formerly known as the Association of Trial Lawyers of America) works to make sure people have a fair chance to receive justice through the legal system when they are injured by the negligence or misconduct of others--even when it means taking on the most powerful corporations. Visit http://www.justice.org.
|SOURCE American Association for Justice|
Copyright©2012 PR Newswire.
All rights reserved